Drug recall
Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC…
FDA recall event 63967 · Class II · West-ward Pharmaceutical Corp.
Key facts
| Event ID | 63967 |
|---|---|
| Recall numbers | D-132-2013 |
| Recalling firm | West-ward Pharmaceutical Corp. |
| Product type | Drugs |
| Products | Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets. |
| Initiation date | Nov 30, 2012 |
| Report date | Jan 30, 2013 |
| Termination date | Jul 9, 2014 |
| City | Eatontown |
| State | NJ |
| Country | United States |
| FEI number | 2250102 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: